| Literature DB >> 19097824 |
R Iorio1, G Frisullo, V Nociti, K A Patanella, A Bianco, A Marti, M Mirabella, P A Tonali, A P Batocchi.
Abstract
In pregnant women affected by multiple sclerosis (MS) we observed increased percentages of CD4(+)CD25(+)Foxp3(+) T regulatory cells at the 1st and the 2nd trimester of gestation that was associated with a decreased T-bet expression in CD4(+) T cells. In women showing clinical relapse and/or new lesions at MRI after delivery we found, a higher expression of T-bet, pSTAT1 and pSTAT3 in CD4(+), CD8(+) T cells and CD14(+) cells, associated with an increase of IFNgamma and IL17 production by PBMC at the 3rd trimester of gestation and after delivery. Our data suggest that the expansion of circulating CD4(+)CD25(+)Foxp3(+) regulatory T cells and the lower expression of T-bet in CD4(+) T cells may account for the decreased MS activity during pregnancy. The expression of T-bet, pSTAT1 and pSTAT3 in peripheral blood CD4(+) and CD8(+) T cells and monocytes could be useful to identify MS patients who will develop a relapse after delivery.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19097824 DOI: 10.1016/j.clim.2008.10.013
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969